SAN FRANCISCO and GENEVA, May 6, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the discovery and development of novel diagnostics and therapeutics related to cell cycle dysregulation, endoplasmic reticulum stress, neurodegeneration and apoptosis, today announced that it has opened an office in Geneva, Switzerland, in preparation for the establishment of a Swiss affiliate. The main purpose of this office is to facilitate interaction with the European biotechnology, pharmaceutical Research and Development and investment communities.
Help employers find you! Check out all the jobs and post your resume.
